END SEPSIS INC

EIN: 461021898 501(c)(3) Diseases & Disorders

NEW YORK, NY

Total Revenue
$367,886
Total Expenses
$378,840
Total Assets
$478,053
Net Assets
$475,292
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2015
Legal Domicile
NY
Principal Officer
CIARAN STAUNTON
Phone
2122446294
Tax Period
2020-01-01 to 2020-12-31

END SEPSIS INC, founded in 2015, is a small nonprofit in the Diseases & Disorders sector that reported $368K in total revenue in fiscal year 2020. Revenue fell 29% from the prior year — a significant decline worth monitoring.

Mission

TO PREVENT UNNECESSARY DEATH AND ILLNESS FROM SEPSIS THROUGH AWARENESS, EDUCATION, AND PROTOCOLS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2020)

Revenue Breakdown

Contributions & Grants $367,886
Program Service Revenue $0
Investment Income $0
Other Revenue $0
TOTAL REVENUE $367,886

Expense Breakdown

Grants Paid $0
Salaries & Benefits $245,453
Fundraising Expenses $16,235
Program Expenses $332,501
Other Expenses $133,387
TOTAL EXPENSES $378,840

Year-over-Year Comparison

2020 2019 Change
Revenue $367,886 $514,727 -0.3%
Expenses $378,840 $411,341 -0.1%
Net Income $-10,954 $103,386 -1.1%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
3
Independent Members
1
Employees
3
Volunteers
25

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
1
$53,000
Total Directors
6
$53,000
Key Employees
0
$0
Highest Compensated
1
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
CIARAN STAUNTON DIRECTOR 40.00
Officer Director
$53,000 $0 $53,000
NIALL O'DOWD DIRECTOR 2.00
Director
$0 $0 $0
ROSEMARY DEVLIN DIRECTOR 2.00
Director
$0 $0 $0
LUCIA DESPAGNO DIRECTOR 2.00
Director
$0 $0 $0
ANNE GOLDMAN DIRECTOR 2.00
Director
$0 $0 $0
DR EDWARD CONWAY DIRECTOR 2.00
Director
$0 $0 $0
ORLAITH STAUNTON CO-FOUNDER 30.00
Highest
$142,000 $0 $142,000
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2020 $367,886 $378,840 $478,053 $-10,954
2019 $514,727 $411,341 $488,313 $103,386
2018 $566,400 $455,870 $385,760 $110,530
Explore More Nonprofits
Top 100 Nonprofits in New York Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare END SEPSIS INC with other nonprofits in New York and across the country.